October News 2022
October 27, 2022
Insomnia impact survey highlights disconnect in patient/doctor perspective
Sleep Review
Results from an online survey, Wake Up America: The Night & Day Impact of Insomnia, brought to life the complexities of insomnia and highlight changes needed to improve the ability of patients and healthcare providers to address this prevalent sleep/wake disorder. Conducted by the Alliance for Sleep, in conjunction with The Harris Poll, the online survey revealed that trouble sleeping and insomnia have a massive impact on a variety of aspects across people’s lives — during both the day and night.
October 20, 2022
Cleveland Clinic study links sleep disorders with more severe outcomes from COVID-19
Cleveland Clinic
A recent Cleveland Clinic study found that people with certain sleep disorders, like sleep apnea, had more severe outcomes with COVID-19, including a 31% higher rate of hospitalization and mortality. Dr. Reena Mehra, MD, director of sleep disorders research for Cleveland Clinic, said while those with sleep apnea, or those who experience lowered oxygen while sleeping, did have more severe outcomes with COVID-19, they were not at a higher risk for contracting the virus.
October 14, 2022
Is sleep apnea genetic?
Sleep Review
In extremely rare cases, central sleep apnea can be linked to genetics, but genes are a much more common culprit in obstructive sleep apnea. Some studies estimate that nearly 75% of people with obstructive sleep apnea inherited the disorder in some way. Sleep Review explores the different types of sleep apnea, how genetics may be involved, and what to expect with a sleep apnea diagnosis.
October 12, 2022
Drug reduced frequency of breathing pauses in sleep apnea
Neuroscience News
A new University of Gothenburg study has paved the way for the first drug treatment for sleep apnea. Sulthiame, a CA inhibitor drug, reduced the number of breathing pauses and promoted oxygenation during the night in sufferers of obstructive sleep apnea.
October 6, 2022
SomnoMed Introduces Smart Oral Appliance That Measures Efficacy & Adherence
Sleep Review
SomnoMed Ltd recently introduced Rest Assure, its first ever technology-enabled oral appliance, which transfers efficacy and adherence data to cloud-based servers, allowing physicians and dentists to see the results. It also allows for data viewing via a patient-facing smartphone app.